Disease severity and costs among patients starting a treatment with COX-2 specific inhibitors versus NSAIDs patients in Italy: Quantitative assessment in 442 patients with arthritis

被引：0

作者：

Lucioni, C

Chinellato, A

Mazzi, S

Roggeri, D

Chiroli, S

机构：

[1] Adis Int Ltd, Milan, Italy

[2] Serv Farmaceut Terr, Treviso, Italy

[3] Pharmacia Italia SpA, Milan, Italy

来源：

VALUE IN HEALTH | 2002年 / 5卷 / 06期

关键词：

D O I：

10.1016/S1098-3015(10)61270-3

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：476 / 477

页数：2

共 50 条

[1] Satisfaction and preferences for NSAIDs and COX-2 specific inhibitors among patients with rheumatoid arthritis.
Wolfe, F
Michaud, K
Zhao, SZ
Burke, TA
Pettitt, D
ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S172 - S172
[2] Are selective COX-2 inhibitors as effective as NSAIDs in patients with rheumatoid arthritis?
Smucny, J
AMERICAN FAMILY PHYSICIAN, 2004, 69 (03) : 595 - 596
[3] COX-2 Inhibitors in Patients with Sensitivity to Nonselective NSAIDs
Cimbollek, Stefan
Quiralte, Joaquin
Avila, Robledo
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (22): : 2197 - 2198
[4] Drug switching patterns among patients with rheumatoid arthritis and osteoarthritis using COX-2 specific inhibitors and non-specific NSAIDs
Zhao, SZ
Wentworth, C
Burke, TA
Makuch, RW
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2004, 13 (05) : 277 - 287
[5] Are COX-2 selective inhibitors safer than NSAIDs for patients with osteoarthritis and rheumatoid arthritis?
Lanas, Angel
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2007, 4 (12): : 648 - 649
[6] Are COX-2 selective inhibitors safer than NSAIDs for patients with osteoarthritis and rheumatoid arthritis?
Angel Lanas
Nature Clinical Practice Gastroenterology & Hepatology, 2007, 4 : 648 - 649
[7] Tolerance of selective inhibitors of COX-2 in patients allergics to NSAIDS
Chamorro, C.
Ventura, I
Aroca, R.
Vega, A.
Guardia, P.
de, Luque, V
Conde, J.
Monteseirin, J.
ALLERGY, 2008, 63 : 204 - 204
[8] Tolerability of selective COX-2 inhibitors in patients with hypersensitivity to NSAIDs
Pagani, M.
Bonadonna, P.
Senna, G.
Antico, A.
Passalacqua, G.
ALLERGY, 2008, 63 : 588 - 588
[9] Increase in lifetime adverse drug reactions, service utilization, and disease severity among patients who will start COX-2 specific inhibitors: Quantitative assessment of channeling bias and confounding by indication in 6689 patients with rheumatoid arthritis and osteoarthritis
Wolfe, F
Flowers, N
Burke, TA
Arguelles, LM
Pettitt, D
JOURNAL OF RHEUMATOLOGY, 2002, 29 (05) : 1015 - 1022
[10] Use of COX-2 specific inhibitors in operative and nonoperative management of patients with arthritis
Goodman, SB
ORTHOPEDICS, 2000, 23 (07) : S765 - S768

← 1 2 3 4 5 →